-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SGmGLiwsSi9w8gm4egfTkVzOS+Q6IQ2wE5x2dwGike8UFL53G0+oP4JhOmGj4QUR 9AxpKJs5AMjNNRHrCqTiPA== 0001013594-09-001355.txt : 20090709 0001013594-09-001355.hdr.sgml : 20090709 20090709174855 ACCESSION NUMBER: 0001013594-09-001355 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090630 FILED AS OF DATE: 20090709 DATE AS OF CHANGE: 20090709 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 801 CORPORATE CENTER DRIVE STREET 2: SUITE 210 CITY: RALEIGH STATE: NC ZIP: 27607 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 801 CORPORATE CENTER DRIVE STREET 2: SUITE 210 CITY: RALEIGH STATE: NC ZIP: 27607 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ELLIOTT ASSOCIATES, L.P. CENTRAL INDEX KEY: 0000904495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 09937879 BUSINESS ADDRESS: STREET 1: 712 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125062999 MAIL ADDRESS: STREET 1: 712 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10019 FORMER NAME: FORMER CONFORMED NAME: ELLIOTT ASSOCIATES LP DATE OF NAME CHANGE: 19930513 4 1 bdsifm4-070909_ex.xml X0303 4 2009-06-30 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0000904495 ELLIOTT ASSOCIATES, L.P. 712 FIFTH AVE NEW YORK NY 10019 0 0 1 0 Common Stock 2009-07-07 4 S 0 13158 6.1243 D 159405 I (1) Common Stock 2009-07-08 4 S 0 261 6.2500 D 159144 I (1) Elliott Associates, L.P., through its subsidiary, Manchester Securities Corp., a New York corporation ("Manchester"), has an indirect pecuniary interest in the shares of common stock of BioDelivery Sciences International, Inc. ("BDSI"), owned by CDC IV, LLC ("CDC IV"). Manchester owns a majority of the equity interest of CDC IV (but not a controlling interest). On June 4, 2009, the manager of CDC IV delegated to Manchester all of the manager's rights and authority with respect to the investment decisions relating to the equity securities of BDSI owned by CDC IV. On July 7, 2009, CDC IV sold an aggregate of 13,158 shares of Common Stock of BDSI at an average gross price per share of $6.1243. The individual trades made by CDC IV on July 7, 2009, are set forth on Exhibit 1(a) attached hereto. On July 8, 2009, CDC IV sold an aggregate of 261 shares of Common Stock of BDSI at a gross price per share of $6.2500. Elliot Greenberg, VP of Braxton Associates, Inc., as GP of Elliott Capital Advisors, L.P., as GP of Elliott Associates, L.P. 2009-07-09 EX-99 2 bdsiex99-070909.htm JULY 9, 2009

 

EXHIBIT 1(a)

Trades on July 7, 2009

Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.   Title of Security
(Instr. 3)

2. Transaction Date

(Month/
Day/
Year)

2A.Deemed Execution Date, if any

3.Transaction Code (Instr. 8)

4.   Securities Acquired (A) or Disposed of (D)

(Instr. 3, 4 and 5)

5. Amount of
Securities Beneficially
Owned Following

Reported
Transaction(s)

(Instr. 3 and 4)

 

6.Ownership Form: Direct
(D) or

Indirect (I)

(Instr. 4)

7.Nature of Indirect Beneficial Ownership

(Instr. 4)

 

 

(Month/
Day/
Year)

 

 

Code

 

 

V

 

 

Amount

(A)or (D)

 

 

Price

 

 

 

 

Common Stock

7/7/09

 

S

 

1,510

D

$6.1000

171,053

I

(1)

Common Stock

7/7/09

 

S

 

1,200

D

$6.1100

169,853

I

(1)

Common Stock

7/7/09

 

S

 

2,263

D

$6.1200

167,590

I

(1)

Common Stock

7/7/09

 

S

 

7,335

D

$6.1300

160,255

I

(1)

Common Stock

7/7/09

 

S

 

850

D

$6.1500

159,405

I

(1)

 

(1) Elliott Associates, L.P., through its subsidiary, Manchester Securities Corp., a New York corporation (“Manchester”), has an indirect pecuniary interest in the shares of common stock of BioDelivery Sciences International, Inc. (“BDSI”), owned by CDC IV, LLC (“CDC IV”). Manchester owns a majority of the equity interest of CDC IV (but not a controlling interest). On June 4, 2009, the manager of CDC IV delegated to Manchester all of the manager’s rights and authority with respect to the investment decisions relating to the equity securities of BDSI owned by CDC IV.

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----